1. Home
  2. CUE vs BESS Comparison

CUE vs BESS Comparison

Compare CUE & BESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$21.68

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

BESS

Bimergen Energy Corporation Common Stock

N/A

Current Price

$4.61

Market Cap

16.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
BESS
Founded
2014
1998
Country
United States
United States
Employees
N/A
3
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
16.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
BESS
Price
$21.68
$4.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$120.00
N/A
AVG Volume (30 Days)
965.7K
199.4K
Earning Date
05-13-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$27,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
195.75
N/A
52 Week Low
$0.17
$2.00
52 Week High
$41.42
$4.93

Technical Indicators

Market Signals
Indicator
CUE
BESS
Relative Strength Index (RSI) 53.90 74.71
Support Level $0.30 $2.03
Resistance Level $41.42 N/A
Average True Range (ATR) 4.04 0.57
MACD -1.89 0.21
Stochastic Oscillator 14.17 89.43

Price Performance

Historical Comparison
CUE
BESS

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About BESS Bimergen Energy Corporation Common Stock

Bimergen Energy Corp is a renewable energy project developer that enables the clean energy transition and provides critical grid stability via solutions across a range of applications through portfolio of utility-scale Battery Energy Storage System (BESS) and solar development projects. Its portfolio includes approximately 23 development-stage utility-scale BESS projects with a projected total storage capacity of around 1.965 gigawatts (GW) and approximately 13 development-stage solar energy projects expected to generate around 1.640 GW upon completion and operation.

Share on Social Networks: